Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success tags : Trial save search
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
BPTH 3 d | $2.92 -31.94% -45.18% 21K
|
Health Technology
|
| O: 72.84%
H: 41.77%
C: -22.37%
bp1002 leukemia trial
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
Published: 2024-03-20 (Crawled : 19:00) - biospace.com/
LIVN | $54.01 3.21% 3.1% 730K
|
Health Technology
|
| O: 1.81%
H: 11.57%
C: 10.5%
success positive trial study
Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
MTNB | $0.18 -4.1% 0.0% 14K
|
Health Technology
|
| O: 4.35%
H: 11.21%
C: -0.46%
mat2203 fda treatment biopharma trial agreement
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
|
| O: 2.56%
H: 0.83%
C: -0.83%
nv-387 covid report treatment trial
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
Published: 2024-02-05 (Crawled : 13:00) - globenewswire.com
ACON | $0.275 -8.18% -8.87% 2.2K
|
n/a
|
| O: -3.78%
H: 2.62%
C: 0.44%
partnership update trial
New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
TNXP | $0.1554 -2.88% -1.33% 1.4M
|
Health Technology
|
| O: 2.78%
H: 6.05%
C: 4.59%
fda fibromyalgia approval hope trial results
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
Published: 2024-01-17 (Crawled : 15:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: -4.74%
H: 1.34%
C: -4.91%
drug trial
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
Published: 2024-01-10 (Crawled : 13:00) - globenewswire.com
VYNE | $2.35 4.44% 3.43% 28K
|
Health Technology
|
| O: 0.0%
H: 4.85%
C: -1.32%
vyn201 biomarker positive treatment trial therapeutics
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
NVO | News | $125.26 2.08% 1.22% 22K
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
treatment glargine trial diabetes insulin
Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease
Published: 2023-12-18 (Crawled : 21:00) - globenewswire.com
SGHT | $5.37 4.68% 4.82% 320K
|
|
| O: -0.3%
H: 8.84%
C: 2.44%
tearcare disease publication treatment sciences eye trial results
Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
Published: 2023-12-14 (Crawled : 12:00) - globenewswire.com
BPTH 3 d | $2.92 -31.94% -45.18% 21K
|
Health Technology
|
| O: 12.22%
H: 0.0%
C: -10.91%
bp1002 first leukemia trial
BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
Published: 2023-12-12 (Crawled : 21:00) - prnewswire.com
BIOL | $0.15 7.91% 6.77% 32K
|
Health Technology
|
| O: 0.0%
H: 3.17%
C: 0.81%
trial laser
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
DYAI A | $1.53 -3.77% -0.63% 460
|
Health Technology
|
| O: -0.85%
H: 5.71%
C: -2.29%
candidate vaccine trial results
Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting
Published: 2023-10-12 (Crawled : 20:00) - globenewswire.com
SGHT | $5.37 4.68% 4.82% 320K
|
|
| O: -0.77%
H: 1.81%
C: -2.07%
tearcare disease presentation treatment sciences meeting eye trial results
Electra Extends Processing of Black Mass Material Based on Successes of its Battery Recycling Trial
Published: 2023-10-02 (Crawled : 14:00) - firstcobalt.com
ELBM | $0.445 -3.26% -3.37% 71K
|
n/a
|
| O: 0.32%
H: 0.0%
C: -4.65%
battery trial
Acurx Pharmaceuticals Announces Successful Completion and Early Discontinuation of the Ibezapolstat Phase 2b Trial for Treatment of C. difficile Infection
Published: 2023-10-02 (Crawled : 11:00) - prnewswire.com
ACXP | $1.98 -1.49% -2.29% 50
|
Professional, Scientific, and T...
|
| O: 4.67%
H: 3.82%
C: -10.19%
ibezapolstat infection treatment pharmaceuticals trial
The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
Published: 2023-08-21 (Crawled : 12:00) - biospace.com/
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
|
| O: 6.2%
H: 6.57%
C: 1.46%
antiviral trial
Response Pharmaceuticals Announces Successful Completion of Phase 1B Clinical Trial for RDX-002, a Novel Small Molecule for the Treatment of Antipsychotic-Induced Weight Gain
Published: 2023-08-17 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
|
| O: 2.95%
H: 0.0%
C: 0.0%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
rdx-002 treatment pharmaceuticals trial response
Therapeutic Solutions International Subsidiary Allogen Biologics Inc. Successfully Manufactures JadiCell Master Cell Bank to Provide Cells for Right to Try Use and Phase III ARDS Clinical Trial
Published: 2023-08-16 (Crawled : 13:00) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: 0.0%
H: 8.33%
C: -8.33%
international cell solutions trial
JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®
Published: 2023-08-10 (Crawled : 12:00) - globenewswire.com
DXR | $9.79 0.41% 0.73% 480
|
Health Technology
|
| O: -1.95%
H: 5.21%
C: 5.21%
bva-100 100 heart trial
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.